Business Segment Information Level 3 (Tables)

9 Months Ended

Dec. 31, 2014

Notes To Financial Statements [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Financial information for each of our segments is presented in the following tables:

	Three Months Ended December 31,						Nine Months Ended December 31,
	2014			2013			2014			2013
Revenues:
Healthcare	$	353,197		$	291,831		$	1,007,176		$	828,051
Life Sciences	67,997			64,128			185,759			182,425
Isomedix	50,960			49,157			154,003			144,792
Total reportable segments	472,154			405,116			1,346,938			1,155,268
Corporate and other	1,090			435			1,678			1,697
Total revenues	$	473,244		$	405,551		$	1,348,616		$	1,156,965
Operating income:
Healthcare	$	33,843		$	31,238		$	81,752		$	72,111
Life Sciences	16,402			12,092			41,395			38,672
Isomedix	12,508			14,054			43,098			42,484
Total reportable segments	62,753			57,384			166,245			153,267
Corporate and other	(1,407		)	(1,494		)	(7,308		)	(6,065		)
Total operating income	$	61,346		$	55,890		$	158,937		$	147,202